Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis.

Source:http://linkedlifedata.com/resource/pubmed/id/15083284

Download in:

View as

General Info

PMID
15083284